Seong Bok Jang

482 total citations
34 papers, 387 citations indexed

About

Seong Bok Jang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Seong Bok Jang has authored 34 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Seong Bok Jang's work include Gastroesophageal reflux and treatments (7 papers), Lipoproteins and Cardiovascular Health (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Seong Bok Jang is often cited by papers focused on Gastroesophageal reflux and treatments (7 papers), Lipoproteins and Cardiovascular Health (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Seong Bok Jang collaborates with scholars based in South Korea, United States and Puerto Rico. Seong Bok Jang's co-authors include Kyungsoo Park, Lay Ahyoung Lim, Jae‐Yong Chung, Min Soo Park, Dong Hwan Lee, Yoon Jung Lee, Dong Woo Han, Ji Ho Choi, Su Youn Nam and Jong‐Eun Lee and has published in prestigious journals such as Anesthesiology, Annals of the Rheumatic Diseases and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Seong Bok Jang

33 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seong Bok Jang South Korea	13	122	100	82	81	62	34	387
Christine Reynolds United States	11	57 0.5×	92 0.9×	62 0.8×	72 0.9×	105 1.7×	15	420
Joanne Burke United States	8	118 1.0×	73 0.7×	95 1.2×	40 0.5×	48 0.8×	11	360
Siv Jönsson Sweden	18	57 0.5×	112 1.1×	88 1.1×	172 2.1×	89 1.4×	50	901
Lai Tham United States	11	98 0.8×	148 1.5×	153 1.9×	76 0.9×	19 0.3×	21	508
Marie‐Noëlle Bizot France	8	54 0.4×	73 0.7×	55 0.7×	52 0.6×	221 3.6×	8	420
Michael J. Knauer Canada	12	126 1.0×	191 1.9×	92 1.1×	101 1.2×	78 1.3×	25	603
Jong‐Lyul Ghim South Korea	15	117 1.0×	74 0.7×	128 1.6×	58 0.7×	88 1.4×	58	666
Nassim Djebli France	14	89 0.7×	158 1.6×	155 1.9×	166 2.0×	36 0.6×	30	678
Vaishali Sahasrabudhe United States	15	104 0.9×	90 0.9×	70 0.9×	69 0.9×	35 0.6×	35	503
Nancy C. Sambol United States	14	118 1.0×	98 1.0×	67 0.8×	114 1.4×	148 2.4×	27	763

Countries citing papers authored by Seong Bok Jang

Since Specialization

Citations

This map shows the geographic impact of Seong Bok Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seong Bok Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seong Bok Jang more than expected).

Fields of papers citing papers by Seong Bok Jang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seong Bok Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seong Bok Jang. The network helps show where Seong Bok Jang may publish in the future.

Co-authorship network of co-authors of Seong Bok Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Seong Bok Jang. A scholar is included among the top collaborators of Seong Bok Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seong Bok Jang. Seong Bok Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Hyun A., Hyun A. Lee, Kyeong‐Ryoon Lee, et al.. (2022). A population PK–PD model of YH4808, a novel P‐CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808. CPT Pharmacometrics & Systems Pharmacology. 11(9). 1223–1233. 1 indexed citations

Lee, Jungwook, et al.. (2022). Effects of Acid-Reducing Agents on the Pharmacokinetics of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. Advances in Therapy. 39(10). 4757–4771.

Jang, Seong Bok, et al.. (2021). A population pharmacokinetic‐pharmacodynamic model of YH12852, a highly selective 5‐hydroxytryptamine 4 receptor agonist, in healthy subjects and patients with functional constipation. CPT Pharmacometrics & Systems Pharmacology. 10(8). 902–913. 3 indexed citations

Jang, Seong Bok, Byoung Chul Cho, Myung‐Ju Ahn, et al.. (2021). Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies. JTO Clinical and Research Reports. 2(10). 100224–100224. 11 indexed citations

Jeon, Ji‐Young, et al.. (2021). Pharmacokinetics of a New, Once-Daily, Sustained-release Pregabalin Tablet in Healthy Male Volunteers. Clinical Therapeutics. 43(8). 1381–1391.e1. 5 indexed citations

Jang, Seong Bok, et al.. (2019). A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+-competitive acid blocker. European Journal of Pharmaceutical Sciences. 130. 1–10. 4 indexed citations

Jung, Jin Ah, Jung‐Ryul Kim, Jae‐Wook Ko, et al.. (2015). A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects. Drug Design Development and Therapy. 9. 745–745. 17 indexed citations

Chae, Dongwoo, et al.. (2015). Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects. International Journal of Clinical Pharmacology and Therapeutics. 53(10). 883–889. 6 indexed citations

Lee, Dong Hwan, et al.. (2014). Pharmacokinetic Interaction Between Rosuvastatin and Telmisartan in Healthy Korean Male Volunteers: A Randomized, Open-label, Two-period, Crossover, Multiple-dose Study. Clinical Therapeutics. 36(8). 1147–1158. 30 indexed citations

10.

Choi, Hee Youn, et al.. (2012). Bioavailability and Tolerability of Combination Treatment With Revaprazan 200 mg + Itopride 150 mg: A Randomized Crossover Study in Healthy Male Korean Volunteers. Clinical Therapeutics. 34(9). 1999–2010. 10 indexed citations

11.

Cho, Sung Kweon, et al.. (2012). Bioequivalence and Dose Proportionality of Olmesartan Medoxomil Formulations. 20(2). 145–145. 1 indexed citations

12.

Jang, Seong Bok, et al.. (2011). Population pharmacokinetics of amikacin in a Korean clinical population. International Journal of Clinical Pharmacology and Therapeutics. 49(6). 371–381. 12 indexed citations

13.

Chung, Jae‐Yong, Sung Kweon Cho, Dong Hwan Lee, et al.. (2011). Effect of HMGCR Variant Alleles on Low‐Density Lipoprotein Cholesterol—Lowering Response to Atorvastatin in Healthy Korean Subjects. The Journal of Clinical Pharmacology. 52(3). 339–346. 22 indexed citations

14.

Lee, Dong Hwan, Lay Ahyoung Lim, Seong Bok Jang, et al.. (2011). Pharmacokinetic Comparison of Sustained- and Immediate-Release Oral Formulations of Cilostazol in Healthy Korean Subjects: A Randomized, Open-Label, 3-Part, Sequential, 2-Period, Crossover, Single-Dose, Food-Effect, and Multiple-Dose Study. Clinical Therapeutics. 33(12). 2038–2053. 13 indexed citations

15.

Han, Dong Woo, Kyungsoo Park, Seong Bok Jang, & Steven E. Kern. (2010). Modeling the Effect of Sevoflurane on Corrected QT Prolongation. Anesthesiology. 113(4). 806–811. 26 indexed citations

16.

Lee, Yong‐Jae, Min Goo Lee, Lay Ahyoung Lim, Seong Bok Jang, & Jae‐Yong Chung. (2010). Effects of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of atorvastatin and 2-hydroxyatorvastatin in healthy Korean subjects. International Journal of Clinical Pharmacology and Therapeutics. 48(1). 36–45. 31 indexed citations

17.

Chung, Jae‐Yong, Seong Bok Jang, Yoon Jung Lee, Min Soo Park, & Kyungsoo Park. (2010). Effect of CYP2B6 Genotype on the Pharmacokinetics of Sibutramine and Active Metabolites in Healthy Subjects. The Journal of Clinical Pharmacology. 51(1). 53–59. 16 indexed citations

18.

Jang, Seong Bok, Yoon Jung Lee, Lay Ahyoung Lim, et al.. (2010). Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: A randomized, open-label, parallel-group, single- and multiple-dose study. Clinical Therapeutics. 32(1). 206–216. 16 indexed citations

19.

Chung, Jae‐Yong, Yoon Jung Lee, Seong Bok Jang, et al.. (2010). CYP3A5*3 Genotype Associated With Intrasubject Pharmacokinetic Variation Toward Tacrolimus in Bioequivalence Study. Therapeutic Drug Monitoring. 32(1). 67–72. 33 indexed citations

20.

Choi, Ji Ho, et al.. (2007). Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects. British Journal of Clinical Pharmacology. 64(2). 185–191. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact